GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Goodwill

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Goodwill : $10.4 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Goodwill?

A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Medexus Pharmaceuticals's goodwill for the quarter that ended in Dec. 2023 was $10.4 Mil.


Medexus Pharmaceuticals Goodwill Historical Data

The historical data trend for Medexus Pharmaceuticals's Goodwill can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Goodwill Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Goodwill
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 10.06 10.65 10.69 10.28

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Goodwill Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.28 10.28 10.39 10.29 10.40

Medexus Pharmaceuticals Goodwill Calculation

A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Goodwill is considered an intangible asset because it is not a physical asset like buildings or equipment. The goodwill account can be found in the assets portion of a company's balance sheet.


Medexus Pharmaceuticals  (OTCPK:MEDXF) Goodwill Explanation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Medexus Pharmaceuticals's Goodwill-to-Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Goodwill-to-Asset (A: Mar. 2023 )=Goodwill/Total Assets
=10.28/161.329
=0.06

Medexus Pharmaceuticals's Goodwill-to-Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Goodwill-to-Asset (Q: Dec. 2023 )=Goodwill/Total Assets
=10.4/160.377
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Medexus Pharmaceuticals Goodwill Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Goodwill provided by GuruFocus.com. Please click on the following links to see related term pages.


Medexus Pharmaceuticals (Medexus Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Headlines

From GuruFocus

Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call

By GuruFocusNews GuruFocusNews 06-24-2022

Treosulfan Pivotal Study Results Published

By GuruFocusNews GuruFocusNews 07-06-2022

Medexus Welcomes Two New Board Members

By Stock market mentor Stock market mentor 02-06-2023

Medexus Schedules First Quarter 2023 Conference Call

By GlobeNewswire GlobeNewswire 08-02-2022

Medexus Schedules Second Quarter 2023 Conference Call

By Value_Insider Value_Insider 11-02-2022

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

By GlobeNewswire GlobeNewswire 01-31-2023